Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0002042266-26-000002

Director sold 556,000 shares at $4.96 ($2,755,981)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foundation Fighting Blindness Retinal Degeneration Fund Director 2026-09-30 Sale −556,000 $4.96 $2,755,981 3,236,171 D: show line 1 in the form
Open-market sales · 556,000 sh · avg $4.96 · $2,755,981
Loading xslF345X06/primary_doc.xml…